Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione

Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione

US Patent 11628172 · Granted Apr 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating multiple myeloma and the use of companion biomarkers for 4-2025
Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Methods and combinations for treatment and T cell modulation2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Anti-CCR7 antibody drug conjugates2024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22024
Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((22024